Search
Menu
Home
HTB
2009
February
09
HTB
9 February 2009
Contents
Antiretrovirals
Maraviroc safety label changes included with US traditional approval
US approval of paediatric abacavir
EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease
Applications to approve non-refrigerated ritonavir submitted to EMEA and FDA
PK and drug interactions
Elvitegravir with tipranavir/ritonavir or darunavir/ritonavir
Serum bilirubin increases when PEG-interferon and ribavirin are used with atazanavir
Drug interactions with integrase inhibitors
Drug interactions between efavirenz and itraconazole
Effect on tacrolimus when switching from nelfinavir to fosamprenavir
HTB RSS
Current issues
April 2024
March 2024
February 2024
Back issues
Special report
Uganda Court rejects appeal against the LGBTQ+ hate law
5 April 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage